We provide you with 20 years of free, institutional-grade data for LGND stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of LGND. Explore the full financial landscape of LGND stock.
Total insider purchase within 3 month on this page: $0
Total insider selling within 3 month on this page: -$2,176,281
| Name | Action | Shares | Avg Price | Amount | Reported Date |
|---|---|---|---|---|---|
| Zimmermann Martine | Sale | -115 | $170.77 | $19,639 | 2025-09-24 |
| Aryeh Jason | Sale | -10,000 | $170.41 | $1,704,051 | 2025-09-24 |
| KOZARICH JOHN W | Sale | -467 | $161.51 | $75,427 | 2025-09-04 |
| Reardon Andrew | Sale | -1,325 | $150.06 | $198,830 | 2025-08-12 |
| KOZARICH JOHN W | Sale | -467 | $131.88 | $61,586 | 2025-08-05 |
| KOZARICH JOHN W | Sale | -934 | $125 | $116,750 | 2025-07-11 |
| Reardon Andrew | Sale | -500 | $114.08 | $57,042 | 2025-06-24 |
| Reardon Andrew | Sale | -500 | $114.54 | $57,271 | 2025-06-12 |
| KOZARICH JOHN W | Grant, award...etc | 1,209 | 2025-06-10 | ||
| Sabba Stephen L | Grant, award...etc | 1,209 | 2025-06-10 | ||
| Zimmermann Martine | Sale | -188 | $105.99 | $19,926 | 2025-06-10 |
| Zimmermann Martine | Grant, award...etc | 1,209 | 2025-06-10 | ||
| Haas Jason | Grant, award...etc | 1,209 | 2025-06-10 | ||
| Aryeh Jason | Grant, award...etc | 1,209 | 2025-06-10 | ||
| LAMATTINA JOHN L | Grant, award...etc | 1,209 | 2025-06-10 | ||
| Gray Nancy Ryan | Grant, award...etc | 1,209 | 2025-06-10 | ||
| Reardon Andrew | Sale | -1,897 | $100.16 | $189,994 | 2025-06-02 |
| KOZARICH JOHN W | Derivatives Exercise | 2,406 | 2025-06-02 | ||
| Espinoza Octavio | Open Market Purchase | 1,500 | $103.89 | 2025-05-13 | |
| Davis Todd C | Open Market Purchase | 9,510 | $104.57 | 2025-05-13 | |
| Sabba Stephen L | Derivatives Exercise | 2,406 | 2025-04-16 | ||
| Reardon Andrew | Grant, award...etc | 6,415 | 2025-03-06 | ||
| Espinoza Octavio | Grant, award...etc | 7,484 | 2025-03-06 | ||
| Espinoza Octavio | Sale | -5,000 | $115.03 | $575,149 | 2025-03-06 |
| Davis Todd C | Grant, award...etc | 21,382 | 2025-03-06 | ||
| Reardon Andrew | Sale | -6,523 | $120 | $782,760 | 2025-02-19 |
| Reardon Andrew | Grant, award...etc | 12,357 | 2025-02-19 | ||
| Espinoza Octavio | Sale | -9,587 | $120 | $1,150,440 | 2025-02-19 |
| Espinoza Octavio | Grant, award...etc | 12,819 | 2025-02-19 | ||
| Davis Todd C | Sale | -13,452 | $120 | $1,614,240 | 2025-02-19 |
| Davis Todd C | Grant, award...etc | 20,784 | 2025-02-19 | ||
| Espinoza Octavio | Sale | -2,104 | $116.37 | $244,850 | 2024-12-26 |
| Espinoza Octavio | Sale | -1,859 | $123.51 | $229,605 | 2024-12-06 |
| LAMATTINA JOHN L | Sale | -2,406 | $123.65 | $297,502 | 2024-12-02 |
| LAMATTINA JOHN L | Derivatives Exercise | 2,406 | 2024-12-02 | ||
| Reardon Andrew | Sale | -2,000 | $99.6 | $199,201 | 2024-09-25 |
| Reardon Andrew | Derivatives Exercise | 2,000 | 2024-09-25 | ||
| Espinoza Octavio | Sale | -1,275 | $103.98 | $132,575 | 2024-09-24 |
| Korenberg Matthew E | Sale | -16,047 | $104.1 | $1,670,520 | 2024-09-24 |
| Korenberg Matthew E | Derivatives Exercise | 14,754 | 2024-09-24 | ||
| Espinoza Octavio | Derivatives Exercise | 1,486 | 2024-09-19 | ||
| Korenberg Matthew E | Sale | -3,214 | $105 | $337,470 | 2024-09-18 |
| Korenberg Matthew E | Derivatives Exercise | 5,774 | 2024-09-18 | ||
| Espinoza Octavio | Derivatives Exercise | 753 | 2024-08-30 | ||
| Reardon Andrew | Sale | -1,500 | $106.39 | $159,591 | 2024-08-30 |
| Reardon Andrew | Derivatives Exercise | 1,500 | 2024-08-30 | ||
| Korenberg Matthew E | Sale | -18,858 | $105.54 | $1,990,273 | 2024-08-26 |
| Korenberg Matthew E | Sale | -18,245 | $98.5 | $1,797,133 | 2024-08-13 |
| Davis Todd C | Open Market Purchase | 2,500 | $97.39 | 2024-08-09 | |
| Sabba Stephen L | Grant, award...etc | 1,252 | 2024-06-25 | ||
| Aryeh Jason | Grant, award...etc | 1,252 | 2024-06-18 | ||
| Gray Nancy Ryan | Grant, award...etc | 1,252 | 2024-06-18 | ||
| LAMATTINA JOHN L | Grant, award...etc | 1,252 | 2024-06-18 | ||
| Zimmermann Martine | Grant, award...etc | 1,252 | 2024-06-18 | ||
| KOZARICH JOHN W | Grant, award...etc | 1,252 | 2024-06-18 | ||
| Haas Jason | Grant, award...etc | 1,252 | 2024-06-18 | ||
| Espinoza Octavio | Derivatives Exercise | 6,917 | 2024-05-17 | ||
| Espinoza Octavio | Sale | -13,293 | $86.01 | $1,143,358 | 2024-05-17 |
| Gray Nancy Ryan | Sale | -934 | $83.2 | $77,713 | 2024-05-17 |
| Korenberg Matthew E | Sale | -17,598 | $84.54 | $1,487,789 | 2024-05-15 |
| Reardon Andrew | Sale | -10,000 | $83.04 | $830,449 | 2024-05-13 |
| Reardon Andrew | Derivatives Exercise | 10,000 | 2024-05-13 | ||
| Aryeh Jason | Derivatives Exercise | 2,406 | 2024-05-02 | ||
| KOZARICH JOHN W | Derivatives Exercise | 2,893 | 2024-04-26 | ||
| Davis Todd C | Derivatives Exercise | 16,015 | 2024-03-27 | ||
| Sabba Stephen L | Sale | -1,893 | $74.3 | $140,650 | 2024-03-07 |
| Sabba Stephen L | Derivatives Exercise | 2,893 | 2024-03-07 | ||
| Aryeh Jason | Derivatives Exercise | 2,893 | 2024-03-06 | ||
| Davis Todd C | Grant, award...etc | 32,436 | 2024-02-29 | ||
| Espinoza Octavio | Sale | -140 | $88.46 | $12,384 | 2024-02-29 |
| Espinoza Octavio | Derivatives Exercise | 1,264 | 2024-02-29 | ||
| Espinoza Octavio | Grant, award...etc | 7,208 | 2024-02-29 | ||
| Reardon Andrew | Grant, award...etc | 7,208 | 2024-02-29 | ||
| Korenberg Matthew E | Grant, award...etc | 14,416 | 2024-02-29 | ||
| Espinoza Octavio | Sale | -1,479 | $74.65 | $110,407 | 2024-02-16 |
| Davis Todd C | Sale | -1,381 | $74.65 | $103,092 | 2024-02-16 |
| Korenberg Matthew E | Sale | -4,778 | $74.65 | $356,678 | 2024-02-16 |
| Reardon Andrew | Sale | -593 | $74.65 | $44,267 | 2024-02-16 |
| Korenberg Matthew E | Sale | -2,917 | $72.31 | $210,928 | 2024-01-04 |
| Korenberg Matthew E | Sale | -1,984 | $59.61 | $118,266 | 2023-12-06 |
| Espinoza Octavio | Sale | -1,269 | $59.61 | $75,645 | 2023-12-06 |
| Espinoza Octavio | Sale | -346 | $59.92 | $20,732 | 2023-10-03 |
| Zimmermann Martine | Grant, award...etc | 2,285 | 2023-09-26 | ||
| Davis Todd C | Open Market Purchase | 4,000 | $59.38 | 2023-09-25 | |
| Reardon Andrew | Sale | -897 | $68.73 | $61,651 | 2023-08-14 |
| Sabba Stephen L | Grant, award...etc | 1,142 | 2023-06-21 | ||
| KOZARICH JOHN W | Grant, award...etc | 1,142 | 2023-06-13 | ||
| LAMATTINA JOHN L | Grant, award...etc | 1,142 | 2023-06-13 | ||
| Aryeh Jason | Grant, award...etc | 1,142 | 2023-06-13 | ||
| Haas Jason | Grant, award...etc | 1,142 | 2023-06-13 | ||
| Davis Todd C | Sale | -420 | $73.76 | $30,979 | 2023-06-13 |
| Gray Nancy Ryan | Grant, award...etc | 1,142 | 2023-06-13 | ||
| KOZARICH JOHN W | Sale | -4,444 | $77.2 | $343,081 | 2023-05-18 |
| Sabba Stephen L | Sale | -6,408 | $77.13 | $494,225 | 2023-05-12 |
| Sabba Stephen L | Derivatives Exercise | 6,408 | 2023-05-12 | ||
| KOZARICH JOHN W | Sale | -6,408 | $76.51 | $490,282 | 2023-05-10 |
| KOZARICH JOHN W | Derivatives Exercise | 6,408 | 2023-05-10 | ||
| Reardon Andrew | Sale | -300 | $69.92 | $20,977 | 2023-03-28 |
The information provided in this report about LGND stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Ligand Pharmaceuticals Incorporated(NASDAQ:LGND) 